$EDU

New Oriental Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026

New Oriental (NYSE: EDU, SEHK: 9901) filed its annual report on Form 20-F for the fiscal year ended May 31, 2026, with the SEC. The report is available on the company's investor relations website and the SEC's website. New Oriental also published its annual report for Hong Kong purposes on its website and the HKEX's website. The company offers private educational services in China and is listed on both the NYSE and SEHK.

Original reporting
Published Sep 22, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EDU
Neutral
high confidence
Mentioned
$EDU
Relevance
5/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$EDUNeutralLow
01

Why it matters

The filing satisfies SEC disclosure requirements and makes the company's audited FY2026 results publicly available, but no new financial guidance is provided in this announcement.

02

Market read

The announcement is a routine compliance filing with limited immediate trading relevance.

03

What to watch

Potential changes in revenue mix or regulatory environment may be detailed in the report.

Relevance 5/10Novelty 5/10Timing: Sep 22 2026 (today)

Background

New Oriental Education & Technology Group Inc. is a China-based private education provider listed on NYSE (EDU) and HKEX (9901).

Company-level read

Ticker impact

$EDUNeutralHigh confidence
Context

New Oriental filed its FY2026 Form 20-F annual report with the SEC on Sep 22, 2026.

Expected impact

Limited short-term price movement expected.

Evidence & confidence

Annual report filing is routine; no material new guidance or surprise disclosed.

Market effects

Minimal impact on the education services sector; filing is standard compliance.

Primarily relevant to US and Hong Kong investors in EDU.

Low; does not affect broader market trends.

Counterpoint

Investors could view the filing as a chance to reassess valuation if the report reveals hidden risks.

Key entities

  • New Oriental Education & Technology Group Inc.

    Provider of private educational services in China.

Related articles

$EDUHighAI 8/10

New Oriental Education & Technology Group Inc. (EDU): Financial results for FY2026

New Oriental Education & Technology Group Inc. (EDU) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 New Oriental Announces Results for the Fourth Fiscal Quarter and the Fiscal Year Ended May 31, 2026 BEIJING, July 29, 2026 /PRNewswire/ – New Oriental Education & Technology Group Inc. (the “Company” or “New Oriental”) (NYSE: EDU/ 9901.SEHK), a provider of private ed

$EDUMedAI 8/10

New Oriental Announces Results for the Fourth Fiscal Quarter and the Fiscal Year Ended May 31, 2026

New Oriental Education & Technology Group Inc. (NYSE: EDU, 9901.SEHK) reported unaudited results for the fourth quarter and fiscal year ended May 31, 2026. Q4 net revenues rose 23.0% to $1,529.5 million, operating income was $85.8 million, and net income attributable to the company increased 775.8% to $62.2 million. Non-GAAP operating margin reached 7.2% in Q4 and 13.0% for FY2026. The company also declared dividends and repurchased up to $300 million of ADSs/shares.

$RCLHigh

Jefferies upgrades Royal Caribbean stock rating on improved revenue outlook

Jefferies upgraded Royal Caribbean (RCL) to Buy with a $330 price target, citing improved occupancy and revenue per passenger. RCL trades at $282.32, with a P/E ratio of 17.66. Jefferies raised revenue estimates for Q3 2026 and FY 2027, projecting net yield growth and higher EBITDA. Despite lower EPS estimates, the firm increased valuation multiples. Other analysts also upgraded RCL, citing strategic developments and positive yield outlooks.

$NGNEHigh

JPMorgan initiates Neurogene stock rating at Overweight on gene therapy potential

JPMorgan initiated coverage on Neurogene Inc. (NASDAQ: NGNE) with an Overweight rating and a $60.00 price target, citing potential in its gene therapy NGN-401 for Rett syndrome. The stock trades at $25.87, with analysts maintaining a Strong Buy consensus. Neurogene expects key data readouts in 2H27, with a market cap of $518 million and high volatility. Recent analyst adjustments include lowered price targets from H.C. Wainwright and Canaccord, both maintaining Buy ratings.